Anandasabapathy Sharmila
Department of Gastroenterology, Hepatology & Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Gastrointest Cancer Res. 2008 Mar;2(2):81-4.
Barrett's esophagus is highly prevalent in the US population and is the only known precursor of esophageal adenocarcinoma, one of the most lethal and increasingly common cancers in the developed world. Over the past 4 decades, the incidence of esophageal adenocarcinoma has increased some 300% to 500%. This dramatic trend has sparked tremendous interest in the early diagnosis of Barrett's dysplasia. The diagnosis of dysplasia and early cancer in Barrett's esophagus presents a number of challenges. The current standard of random, four-quadrant biopsies has several limitations including sampling error and inconsistent histopathologic interpretation. Emerging technologies in the field of endoscopic microscopy and spectroscopy offer the potential for visual biopsies-real-time, in-situ diagnoses that can be rendered without removing tissue. Used as an adjunct to standard white-light endoscopy, these technologies may enhance the detection of dysplasia and early cancer, thus offering the potential for early diagnosis and improved survival. This article reviews the current status of these novel, optical-based diagnostic technologies and their emerging role in the endoscopic detection of esophageal neoplasia.
巴雷特食管在美国人群中非常普遍,并且是食管腺癌唯一已知的前驱病变,食管腺癌是发达国家中最致命且日益常见的癌症之一。在过去40年中,食管腺癌的发病率增加了约300%至500%。这一显著趋势引发了人们对巴雷特发育异常早期诊断的极大兴趣。巴雷特食管发育异常和早期癌症的诊断存在诸多挑战。当前随机四象限活检的标准存在一些局限性,包括采样误差和组织病理学解释不一致。内镜显微镜检查和光谱学领域的新兴技术提供了进行可视化活检的潜力,即无需切除组织就能进行实时、原位诊断。作为标准白光内镜检查的辅助手段,这些技术可能会提高发育异常和早期癌症的检测率,从而为早期诊断和提高生存率提供可能。本文综述了这些基于光学的新型诊断技术的现状及其在内镜检测食管肿瘤方面的新兴作用。